GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sihuan Pharmaceutical Holdings Group Ltd (OTCPK:SHPHF) » Definitions » 3-Year Dividend Growth Rate

Sihuan Pharmaceutical Holdings Group (Sihuan Pharmaceutical Holdings Group) 3-Year Dividend Growth Rate : 32.20% (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Sihuan Pharmaceutical Holdings Group 3-Year Dividend Growth Rate?

Sihuan Pharmaceutical Holdings Group's Dividends per Share for the six months ended in Dec. 2023 was $0.00.

The historical rank and industry rank for Sihuan Pharmaceutical Holdings Group's 3-Year Dividend Growth Rate or its related term are showing as below:

SHPHF' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -37   Med: -3.75   Max: 53
Current: 32.2

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sihuan Pharmaceutical Holdings Group was 53.00% per year. The lowest was -37.00% per year. And the median was -3.75% per year.

SHPHF's 3-Year Dividend Growth Rate is ranked better than
78.86% of 317 companies
in the Drug Manufacturers industry
Industry Median: 10.2 vs SHPHF: 32.20

During the past 12 months, Sihuan Pharmaceutical Holdings Group's average Dividends Per Share Growth Rate was 131.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 32.20% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 7.60% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -11.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Sihuan Pharmaceutical Holdings Group's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00. As of today, Sihuan Pharmaceutical Holdings Group's Dividend Yield % is 7.27%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Sihuan Pharmaceutical Holdings Group's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sihuan Pharmaceutical Holdings Group's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's 3-Year Dividend Growth Rate falls into.



Sihuan Pharmaceutical Holdings Group 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Sihuan Pharmaceutical Holdings Group  (OTCPK:SHPHF) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Sihuan Pharmaceutical Holdings Group's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=0/ -0.002
=N/A

During the past 13 years, the highest Dividend Payout Ratio of Sihuan Pharmaceutical Holdings Group was 0.38. The lowest was 0.11. And the median was 0.26.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Sihuan Pharmaceutical Holdings Group Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
HKD 0.0370002023-06-072023-06-082023-06-23Cash Dividendsemi-annuallyHKD:USD 0.127611

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Sihuan Pharmaceutical Holdings Group's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.004721607/0.065
=7.26 %

Current Share Price is $0.065.
Sihuan Pharmaceutical Holdings Group's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.004721607.

During the past 13 years, the highest Dividend Yield of Sihuan Pharmaceutical Holdings Group was 7.27%. The lowest was 0.44%. And the median was 1.69%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sihuan Pharmaceutical Holdings Group 3-Year Dividend Growth Rate Related Terms>


Sihuan Pharmaceutical Holdings Group (Sihuan Pharmaceutical Holdings Group) Business Description

Traded in Other Exchanges
Address
Zhubang 2000 Business Centre, 22nd Floor, Building 4, West Balizhuang, Chaoyang District, Beijing, CHN, 100025
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Digestive System, Anti-Infective, metabolism, Respiratory, Neurology, and Others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others to provide non- or minimally invasive medical aesthetics comprehensive solutions; the innovative medicine and other medicine segments; and the generic medicine segment.